Belite Bio’s Tinlarebant  Shines In Phase III Stargardt Disease Trial

 
• By Sushmita Panda
  
A metaphorical picture showing the struggle of suffering from Stargardt disease.
Stargardt disease is a genetic eye disorder that leads to progressive central vision loss, typically starting in childhood or early adulthood. (Shutterstock)

More from Clinical Trials

More from R&D